Finally, to confirm whether the expression of these molecules is indeed affected in AD, we also carried out qPCR and western blot analysis on 7‐8‐month‐old APP/PS1 model mice of AD, which is very popular in AD research and exhibits obvious cognitive impairment at 7–8 months of age. This evidence concerns the gene APP and Alzheimer disease.